Recombinant Mouse Transmembrane protein 140 (Tmem140)

What is Mouse Transmembrane Protein 140 and how is it characterized?

Transmembrane protein 140 (Tmem140) is a protein-coding gene that encodes a membrane-spanning protein. Based on comparative studies with other species, such as Xenopus tropicalis, Tmem140 produces multiple transcript variants that encode the same protein . The protein is relatively conserved across species, suggesting important biological functions.

For characterization of mouse Tmem140:

• Sequence analysis using NCBI Reference Sequence Database is essential for identifying transcript variants

• Protein topology prediction tools can determine transmembrane domains

• Subcellular localization studies using fluorescent-tagged constructs help establish cellular distribution

Mouse Tmem140 characterization would typically include:

What expression patterns does Tmem140 exhibit in normal mouse tissues?

While direct mouse Tmem140 expression data isn't provided in the search results, expression analysis approaches should include:

• Comprehensive tissue panel analysis using quantitative RT-PCR to determine baseline expression

• Immunohistochemistry to visualize protein distribution in tissues

• RNA-sequencing analysis for transcript variant identification

From analogous studies in humans, Tmem140 likely shows differential expression across tissues, with particularly notable expression patterns in neural tissues. When characterizing expression patterns, researchers should:

• Establish appropriate housekeeping genes for normalization

• Compare expression across developmental stages

• Analyze expression in different physiological conditions

• Consider both mRNA and protein levels, as they may not directly correlate

How should recombinant mouse Tmem140 be produced for experimental studies?

Production of recombinant mouse Tmem140 requires careful consideration of expression systems:

• Vector selection:

  • Standard vectors like pcDNA3.1 are suitable for mammalian expression

  • Consider adding epitope tags (His, FLAG, etc.) for purification and detection

  • Include appropriate promoters for desired expression levels

• Expression systems:

  • Mammalian cells (HEK293, CHO) for proper folding and post-translational modifications

  • Bacterial systems for higher yield but potential protein folding issues

  • Insect cell systems as an intermediate option

• Purification strategy:

  • Detergent screening for optimal membrane protein solubilization

  • Affinity chromatography using epitope tags

  • Size exclusion chromatography for final purification

• Quality control:

  • SDS-PAGE and Western blot for size verification

  • Mass spectrometry for identity confirmation

  • Functional assays to verify biological activity

What methodologies are most effective for studying Tmem140 function in mouse models?

Based on approaches used for human TMEM140, effective methodologies include:

• Gene silencing approaches:

  • siRNA transfection in cell models (effectiveness verified by Western blot and RT-PCR)

  • shRNA for stable knockdown

  • CRISPR/Cas9 for complete knockout

• Overexpression studies:

  • Transient transfection for acute effects

  • Stable cell lines for long-term studies

  • Inducible expression systems for temporal control

• In vivo models:

  • Conditional knockout mice to avoid developmental effects if lethal

  • Tissue-specific expression using Cre-lox systems

  • Xenograft models for tumor studies as demonstrated with human TMEM140

• Functional assays:

  • Cell viability assays (e.g., Cell Counting Kit-8)

  • Migration and invasion assays (e.g., Transwell assays)

  • Cell cycle analysis and apoptosis assays using flow cytometry

When designing Tmem140 knockout models, researchers should be aware of potential off-target effects, especially considering possible gene paralogs. Validation through multiple founder lines and complementation studies is essential to confirm phenotype specificity, similar to approaches used for SP140 .

How does Tmem140 influence cellular signaling pathways in mouse models?

While specific mouse data is limited, research approaches should focus on:

• Pathway analysis:

  • Gene Set Enrichment Analysis (GSEA) can identify associated pathways

  • Phosphoproteomic analysis to detect signaling changes

  • Transcriptomic profiling after Tmem140 modulation

• Key pathways to investigate:

  • Apoptosis pathways (based on human studies showing regulation of Bcl2, Bax, and cleaved caspase3)

  • Cell adhesion molecule pathways (ICAM1, VCAM1, Syndecan1)

  • Cell cycle regulation pathways

• Validation experiments:

  • Western blot analysis of key pathway proteins

  • Reporter gene assays for pathway activation

  • Co-immunoprecipitation to identify protein interaction partners

From human glioma studies, TMEM140 silencing significantly affects G0/G1 phase cell cycle progression (increasing cell population in this phase by 53.5% in U87 cells and 43.3% in U373 cells, p<0.001) .

What are the considerations for validating Tmem140 knockout or knockdown specificity?

To ensure experimental rigor when modulating Tmem140 expression:

• Genomic validation:

  • PCR and sequencing to confirm targeted modifications

  • Analysis of potential off-target effects, especially if using CRISPR/Cas9

  • Consideration of gene paralogs that might be affected

• Expression validation:

  • Quantitative RT-PCR to confirm mRNA reduction

  • Western blot analysis to verify protein depletion

  • Immunofluorescence to assess cellular localization changes

• Functional validation:

  • Rescue experiments with wild-type Tmem140 expression

  • Dose-dependent effects with varying levels of knockdown

  • Comparison of multiple independent knockout/knockdown lines

• Controls:

  • Non-targeting siRNA/shRNA controls

  • Wild-type littermates for in vivo studies

  • Analysis of related family members to ensure specific targeting

Drawing from SP140 research methodology, deep sequencing of potential off-target regions and RNA-seq analysis can help confirm the specificity of genetic modifications .

How can Tmem140 function in disease models be effectively investigated?

Based on human TMEM140 studies in glioma:

• Cancer models:

  • Cell line panels representing different cancer types

  • Patient-derived xenografts for translational relevance

  • Genetic mouse models of cancer with Tmem140 modulation

• Experimental design:

  • In vitro studies of cell viability, migration, invasion

  • In vivo tumorigenicity and tumor growth studies

  • Correlative studies of Tmem140 expression with histopathological features

• Clinical correlation:

  • Analysis of Tmem140 expression in patient samples

  • Correlation with clinical parameters (tumor size, grade, survival)

  • Multivariate analysis to establish prognostic value

What technologies are emerging for studying Tmem140 protein interactions and structure?

Advanced methodologies for Tmem140 research include:

• Protein interaction studies:

  • Proximity labeling (BioID, APEX) for membrane protein interactions

  • Co-immunoprecipitation with crosslinking for transient interactions

  • Yeast two-hybrid or mammalian two-hybrid systems

• Structural biology approaches:

  • Cryo-electron microscopy for membrane protein structure

  • X-ray crystallography (challenging for membrane proteins)

  • NMR for dynamic studies of protein regions

• Live-cell imaging:

  • FRET/BRET for protein-protein interactions

  • Super-resolution microscopy for detailed localization

  • Optogenetic tools for temporal control of protein function

• Single-cell analysis:

  • Single-cell RNA-seq for expression heterogeneity

  • Mass cytometry for protein expression at single-cell level

  • Spatial transcriptomics for tissue context analysis

What are common challenges in working with recombinant mouse Tmem140?

Membrane proteins like Tmem140 present specific experimental challenges:

• Expression difficulties:

  • Toxicity when overexpressed

  • Protein misfolding or aggregation

  • Inefficient membrane insertion

• Detection issues:

  • Limited antibody availability and specificity

  • Low expression levels in certain tissues

  • Extraction difficulties from membrane fractions

• Functional assessment:

  • Undefined physiological ligands or binding partners

  • Complex signaling networks with redundancy

  • Context-dependent functions across cell types

How should researchers interpret contradictory findings in Tmem140 studies?

When facing contradictory results:

• Consider biological context:

  • Cell type-specific effects

  • Species differences in protein function

  • Developmental or physiological state variations

• Evaluate methodology:

  • Different knockdown/knockout techniques may have varying specificity

  • Overexpression artifacts versus physiological relevance

  • Acute versus chronic effects of manipulation

• Technical considerations:

  • Antibody specificity verification

  • Validation across multiple experimental systems

  • Dose-dependent effects that may explain contradictions

• Statistical analysis:

  • Appropriate statistical tests for experimental design

  • Consideration of sample sizes and power

  • Biological versus statistical significance

What are promising areas for future mouse Tmem140 research?

Based on current knowledge gaps:

• Physiological functions:

  • Tissue-specific conditional knockout studies

  • Developmental role assessment

  • Interaction with other membrane proteins

• Disease relevance:

  • Beyond cancer: neurological, immunological, or metabolic connections

  • Potential as therapeutic target based on human disease correlations

  • Biomarker potential in mouse models of human disease

• Regulatory mechanisms:

  • Transcriptional regulation

  • Post-translational modifications

  • Trafficking and turnover dynamics

• Therapeutic applications:

  • Development of modulators (inhibitors or activators)

  • Delivery systems for Tmem140-targeting therapies

  • Combination approaches with existing therapies